Mesoblast (MESO) Net Equity Issued and Repurchased (2017 - 2022)

Mesoblast has reported Net Equity Issued and Repurchased for 6 years, with the latest figure at $45.1 million in Q3 2022.

• Quarterly Net Equity Issued and Repurchased rose 30556.46% year-over-year to $45.1 million in Q3 2022, while the trailing twelve-month figure through Mar 2023 was $45.1 million (up 4946.47% YoY) and the FY2022 annual result came in at $209000.0, down 99.8% from the prior year.
• Net Equity Issued and Repurchased climbed to $45.1 million in Q3 2022 per MESO's latest filing, from $62000.0 in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $96.0 million in Q1 2021 and troughed at $34000.0 in Q1 2018.
• A 5-year average of $23.3 million and a median of $4.8 million in 2020 frame the typical range for Net Equity Issued and Repurchased.
• The sharpest annual moves came in 2021 and 2022: Net Equity Issued and Repurchased tumbled 99.27% in 2021, then soared 30556.46% in 2022.
• Over 5 years, Net Equity Issued and Repurchased stood at $20.2 million in 2018, then surged by 151.13% to $50.8 million in 2019, then plunged by 97.18% to $1.4 million in 2020, then tumbled by 95.67% to $62000.0 in 2021, then surged by 72585.48% to $45.1 million in 2022.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $45.1 million, $62000.0, and $147000.0 for Q3 2022, Q4 2021, and Q3 2021 respectively.